Published in J Neuropsychiatry Clin Neurosci on January 01, 2005
Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach. Alzheimers Dement (2006) 1.16
The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials. Alzheimers Dement (2012) 1.16
Behavioral symptoms related to cognitive impairment. Neuropsychiatr Dis Treat (2013) 0.89
Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease. Int J Geriatr Psychiatry (2010) 0.88
Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study. Dement Geriatr Cogn Dis Extra (2012) 0.78
Social cognition in Alzheimer's disease: a separate construct contributing to dependence. Alzheimers Dement (2014) 0.77
Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition. Alzheimer Dis Assoc Disord (2016) 0.76
Agreement in cognitive and clinical assessments in Alzheimer's disease. Dement Geriatr Cogn Disord (2009) 0.76
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77
An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 5.94
Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res (2002) 4.17
Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (2002) 3.26
Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol (2002) 2.89
The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry (1995) 2.11
Executive functions and their disorders. Br Med Bull (2003) 2.07
Executive dysfunction in geriatric depression. Am J Psychiatry (2002) 1.85
Cholinesterase inhibitors: A new class of psychotropic compounds. Am J Psychiatry (2000) 1.62
Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale. Neuropsychiatry Neuropsychol Behav Neurol (2001) 1.37
Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol (2001) 1.37
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.36
Dementias that present with and without posterior cortical features: an important clinical distinction. J Am Geriatr Soc (1998) 1.33
Neuropsychiatric features of frontotemporal dementia: evaluation of consensus criteria and review. J Neuropsychiatry Clin Neurosci (2002) 1.24
Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology (1996) 1.06
A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.05
Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease. J Geriatr Psychiatry Neurol (1999) 1.04
Behavioral syndromes in Alzheimer's disease. Int Psychogeriatr (1992) 0.97
Executive cognitive impairment: a novel perspective on dementia. Neuroepidemiology (2000) 0.96
Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. J Clin Psychiatry (2001) 0.94
Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes. J Geriatr Psychiatry Neurol (2002) 0.94
Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. J Am Geriatr Soc (1997) 0.91
Qualifying change: a method for defining clinically meaningful outcomes of change score computation. J Am Geriatr Soc (2000) 0.91
Clinicometabolic dissociation of cognitive functions and social behavior in frontal lobe lesions. Neurology (1998) 0.91
Longitudinal course of behavioral problems during Alzheimer's disease: linear versus curvilinear patterns of decline. J Gerontol A Biol Sci Med Sci (2000) 0.90
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol (1996) 0.88
Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients. J Clin Psychiatry (2000) 0.86
Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease. J Neuropsychiatry Clin Neurosci (2002) 0.83
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Mild cognitive impairment. Lancet (2006) 10.21
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA (2008) 7.35
The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am (2005) 7.26
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA (2003) 6.34
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res (2002) 4.17
Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (2002) 3.26
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol (2006) 3.11
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain (2006) 2.73
Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology (2011) 2.43
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Arch Neurol (2008) 2.25
Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging (2004) 2.23
Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci (2007) 2.14
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry (2003) 2.07
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain (2007) 1.99
White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol (2003) 1.93
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91
Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86
Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am J Psychiatry (2003) 1.86
A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res (2005) 1.85
A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry (2003) 1.83
Risk factors for potentially harmful informal caregiver behavior. J Am Geriatr Soc (2005) 1.81
Effective pharmacologic management of Alzheimer's disease. Am J Med (2007) 1.79
Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. J Neurosci (2003) 1.75
Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol (2007) 1.75
Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75
DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet (2006) 1.73
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging (2010) 1.70
ADCS Prevention Instrument Project: overview and initial results. Alzheimer Dis Assoc Disord (2006) 1.70
Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci (2002) 1.69
Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord (2007) 1.61
Performance of elderly Native Americans and Caucasians on the CERAD Neuropsychological Battery. Alzheimer Dis Assoc Disord (2005) 1.60
Health-related resource use and costs in elderly adults with and without mild cognitive impairment. J Am Geriatr Soc (2013) 1.59
Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging (2006) 1.58
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep (2003) 1.58
Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol (2007) 1.57
Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging (2007) 1.57
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J Alzheimers Dis (2010) 1.57
Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol (2007) 1.55
Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol (2005) 1.55
Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord (2004) 1.53
What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain (2006) 1.51
Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage (2010) 1.45
Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc (2011) 1.43
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp (2010) 1.40
Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement (2008) 1.39
Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years. Am J Geriatr Psychiatry (2008) 1.39
Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry (2005) 1.38
Dementia with parkinsonism: what is the diagnosis? Rev Neurol Dis (2004) 1.38
Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology (2007) 1.37
Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.35
Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci U S A (2006) 1.34
Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Curr Alzheimer Res (2009) 1.34
The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families. Neurogenetics (2006) 1.31
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord (2010) 1.31
Feasibility of telecognitive assessment in dementia. Assessment (2006) 1.30
Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci (2002) 1.30
Patterns of verbal memory performance in mild cognitive impairment, Alzheimer disease, and normal aging. Cogn Behav Neurol (2006) 1.28
Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol (2007) 1.27
Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J Neuropsychiatry Clin Neurosci (2003) 1.27
Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.25
Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci (2004) 1.23
Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry (2002) 1.23
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging (2010) 1.22
Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry (2006) 1.22
Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci (2003) 1.22
Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype. J Int Neuropsychol Soc (2002) 1.21
The association between midlife cardiorespiratory fitness levels and later-life dementia: a cohort study. Ann Intern Med (2013) 1.21
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol (2008) 1.18
Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Arch Neurol (2009) 1.17
Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach. Alzheimers Dement (2006) 1.16
The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease. J Sleep Res (2003) 1.15
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimers Dement (2012) 1.14
Frontal-subcortical dementias. Neurologist (2008) 1.14
Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J Neurosci (2004) 1.14
Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease. Neuropsychology (2007) 1.13
Neuropsychiatric symptoms in the dementias. Curr Opin Neurol (2002) 1.13
Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med (2004) 1.12
Utility of the telephone interview for cognitive status for enrollment in clinical trials. Alzheimers Dement (2006) 1.10
FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease. Eur Radiol (2005) 1.09
Nerve growth factor promotes survival of new neurons in the adult hippocampus. Neurobiol Dis (2006) 1.09
ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Dis Assoc Disord (2006) 1.08
Reliability of monitoring the clinical dementia rating in multicenter clinical trials. Alzheimer Dis Assoc Disord (2004) 1.07